Newsroom
Sorted by: Latest
-
YMCA of Greater New York and Anthem Expand Lifeguard Training Program to Address NYC Lifeguard Shortage
NEW YORK--(BUSINESS WIRE)--To help address New York City's ongoing lifeguard shortage while creating new employment opportunities, the YMCA of Greater New York, with support from Anthem Blue Cross and Blue Shield, is expanding its Community Lifesavers program across Queens and North Brooklyn. The Community Lifesavers initiative expands access to swim instruction, aquatic safety training, and lifeguard certification in neighborhoods where opportunities have historically been limited. The program...
-
Western Alliance Bank Named #1 Best Bank in Arizona on Forbes 2026 Best-In-State Banks List
PHOENIX--(BUSINESS WIRE)--Western Alliance Bank (NYSE: WAL) today announced that it has been named to the Forbes 2026 America’s Best-in-State Banks List, ranking #1 in Arizona and standing as the only Arizona-based bank included. In its ninth year, the Forbes Best-In-State Banks list is among the industry’s most prestigious recognitions. In partnership with market research firm Statista, Forbes surveyed 26,000 U.S. consumers and analyzed more than 1.2 million public online reviews collected bet...
-
NFL Biosciences Announces the Successful Manufacturing of a GMP Clinical Batch of NFL-102 and Validates Its Industrial Production Chain
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing innovative botanical drugs for the treatment of addictions, announces today the successful manufacturing of a GMP (Good Manufacturing Practice) clinical batch of NFL-102, a new drug candidate for smoking cessation. The analytical controls performed on this batch confirmed its compliance with the expected specifications. This achievement en...
-
NFL Biosciences annonce la fabrication avec succès d’un lot clinique GMP de NFL-102 et valide sa chaîne industrielle de production
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), société biopharmaceutique développant des médicaments botaniques innovants pour le traitement des addictions, annonce aujourd’hui la fabrication avec succès d’un lot clinique GMP (Good Manufacturing Practice) de NFL-102, un nouveau candidat médicament destiné au sevrage tabagique. Les contrôles analytiques réalisés sur ce lot ont confirmé sa conformité aux spécifications attend...
-
Evolution de la gouvernance d’emeis : nominations au sein du comité de direction
PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: Après plus de quatre années de profonde transformation, emeis (Paris:EMEIS) franchit une nouvelle étape. Grâce à l’engagement remarquable des équipes, emeis a retrouvé une trajectoire et une dynamique durables. Aujourd’hui, fort de fondations solides, Laurent Guillot, Directeur Général, fait évoluer son organisation afin d’accompagner la croissance et de poursuivre l’amélioration de la qualité de l’accompagnement des patients, des résidents, de...
-
Changes to emeis’ Governance: Appointments to the Executive Committee
PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: After four years of profound transformation, emeis is entering a new chapter. Thanks to the remarkable commitment of the teams, emeis (Paris:EMEIS) has found itself on a sustainable path with good momentum. Today, building on these solid foundations, Laurent Guillot, Chief Executive Officer, is making changes to emeis’ organisational structure in order to support further growth and continue to improve the quality of care provided to patients, r...
-
Feinstein Institutes secures $4.9M in NIH grants to advance research in acute inflammation and Alzheimer’s disease
MANHASSET, N.Y.--(BUSINESS WIRE)--Tackling two of medicine’s most pressing challenges – acute inflammation and Alzheimer’s disease – Northwell Health’s Feinstein Institutes for Medical Research has successfully acquired $4.9 million in new multi-year grant funding from the National Institutes of Health (NIH). These significant awards will fuel two distinct research projects focused on unraveling fundamental biological mechanisms of acute inflammation and Alzheimer’s disease. The two grants have...
-
Operation HOPE Releases 2025 Annual Report Highlighting Record-Breaking Growth and Transformative Client Results
ATLANTA--(BUSINESS WIRE)--Operation HOPE, a national nonprofit dedicated to helping low-and moderate-income Americans thrive in an ever-changing economy, today announced the release of its 2025 Annual Report. Operation HOPE continued its impressive streak of growth by serving a record number of clients, growing its portfolio of top-tier partner organizations, and improving client outcomes with improved credit scores, increased savings and decreased levels of debt. Operation HOPE uses its HOPE I...
-
Notification of availability of Rémy Cointreau 2025-26 Universal Registration Document
PARIS--(BUSINESS WIRE)--Regulatory News: Rémy Cointreau (Paris:RCO): Rémy Cointreau's 2025-26 Universal Registration Document was filed with the French Financial Markets Authority (AMF) in the European Single Electronic Format (ESEF) on Tuesday, June 30, 2026, under the reference number D.26-0496. The document is publicly available under the current regulatory conditions and can be accessed on Rémy Cointreau's website at www.remy-cointreau.com, in both French and English, within the Finance / P...
-
Notification de mise à disposition par Rémy Cointreau du Document d’Enregistrement Universel 2025-26
PARIS--(BUSINESS WIRE)--Regulatory News: Rémy Cointreau (Paris:RCO): Le document d’enregistrement universel 2025-26 de Rémy Cointreau a été déposé auprès de l’Autorité des marchés financiers (AMF) au format ESEF (European Single Electronic Format) le mardi 30 juin 2026, sous le numéro D.26-0496. Il est tenu à la disposition du public dans les conditions prévues par la réglementation en vigueur et peut être consulté sur le site internet de la société (www.remy-cointreau.com, rubrique Finance / p...